Marites P. Melancon, Ph.D.
The mission of our lab is to develop novel nanomedicine for cancer theranostics.
The main goal of my research is to apply the "seek and treat" strategy in the development of targeted imaging/therapeutic agents that will eventually be translated to the clinic to improve the management of cancer through early tumor detection and individualized therapy. One focus is on the synthesis and characterization of novel nanoparticulate systems that have the ability to non-invasively monitor and treat cellular processes at the molecular level and lead to new ways of diagnosing and characterizing disease, developing effective therapeutics and monitoring response to these treatments. Another focus is the development of radiopaque absorbable medical device to reduce complication and expense of surgical removal of the device and maintain ability to be monitored by medical imaging devices, thus enhance overall safety of the device.
The primary focus of our lab are the following:
- Anticancer nanomedicine
- Nanomedicine in combination with various ablation modalities
- Radiopaque medical device